Hyponatraemia in acute HF: Tolvaptan effective, but does not reduce mortality
02 Jan 2020
byChristina Lau
Tolvaptan improves dyspnoea, increases sodium levels and reduces body weight in patients with acute heart failure (HF) with or without hyponatraemia, but no significant effect is seen in mortality or rehospitalization, according to a recent meta-analysis.
Hyponatraemia in acute HF: Tolvaptan effective, but does not reduce mortality
02 Jan 2020